Highlights
NASDAQ: RTTR       Ritter Pharmac. Com
Last Price Today's Change   Day's Range   Trading Volume
0.174   -0.005 (2.79%)  0.155 - 0.181  2,439,031

Overview

 
Avg Volume (4 weeks):1,096,910
4 Weeks Range:0.155 - 0.264
4 Weeks Price Volatility (%):
17.43%
52 Weeks Range:0.155 - 1.35
52 Weeks Price Volatility (%):
1.59%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Ritter Pharmaceuticals Inc develops novel therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases. Its lead product, RP-G28, has the potential to become the first FDA-approved treatment for lactose intolerance, a condition that affects millions worldwide. The company is further exploring the functionality and discovering the therapeutic potential gut microbiome changes may have on treating/preventing a variety of conditions including: gastrointestinal diseases, immuno-oncology, metabolic, and liver disease.

  Be the first to like this.
 


 

3627  2099  329  2916 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GE 11.44+0.47 
 AMD 42.59+3.12 
 DHR 151.35+1.68 
 CHK 0.791+0.046 
 BAC 34.68+1.04 
 FCEL 0.707+0.144 
 AMRX 5.04+1.56 
 AABA 19.630.00 
 F 9.32+0.21 
Partners & Brokers